Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 512
interventional 402
Observational 102
Registry 8

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 175
Procedure 31
Other 25
Drug|Other 19
Behavioral 18
Drug|Radiation 15
Biological 13
Radiation 11
Biological|Drug 9
Drug|Procedure 8
Behavioral|Other 7
Device 7
Drug|placebo 6
Drug|Procedure|Radiation 6
Diagnostic Test 4
Biological|Drug|Other 3
Biological|Other 3
Device|Drug 3
Other|Procedure 3
Procedure|Radiation 3
Behavioral|Other|Procedure 2
Biological|Drug|placebo 2
Combination Product 2
Device|Other 2
Dietary Supplement 2
Behavioral|Device 1
Behavioral|Dietary Supplement|Other 1
Behavioral|Drug 1
Behavioral|Drug|placebo|Procedure 1
Behavioral|Procedure 1
Biological|Drug|Other|Procedure 1
Biological|Drug|Procedure 1
Biological|Drug|Procedure|Radiation 1
Biological|Drug|Radiation 1
Biological|Other|Radiation 1
Device|Drug|Other 1
Device|Radiation 1
Dietary Supplement|Drug|placebo 1
Dietary Supplement|Drug|Radiation 1
Dietary Supplement|Other 1
Dietary Supplement|Other|Procedure 1
Dietary Supplement|placebo 1
Drug|Genetic|Other 1
Drug|Other|placebo 1
Drug|Other|Procedure 1
Drug|Other|Radiation 1
Drug|placebo|Radiation 1
Other|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 204
France 18
Canada 17
China 13
NA 11
Netherlands 10
United Kingdom 8
United States|Canada 8
Belgium 7
Germany 7
Spain 6
Denmark 4
Italy 4
Sweden 4
Brazil 3
Norway 3
Israel 2
Poland 2
Taiwan 2
Turkey 2
United States|Australia 2
Australia 1
Australia|Hong Kong|New Zealand|United Kingdom 1
Australia|New Zealand|Poland|Russian Federation|Thailand 1
Austria 1
Austria|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Portugal|Slovakia|Spain|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Italy|Netherlands|Portugal|Spain 1
Austria|Belgium|France|Italy|Netherlands|Portugal|Spain|United Kingdom 1
Austria|Belgium|Italy|Portugal|Spain|United Kingdom 1
Austria|Germany 1
Belgium|Canada|France|Italy|Netherlands|Poland|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|Czechia|France|Germany|Ireland|Netherlands 1
Belgium|Czechia|France|Hungary|Latvia|Lithuania|Moldova, Republic of|Poland|Russian Federation|Spain|Ukraine|United Kingdom 1
Belgium|Denmark 1
Belgium|Denmark|France|Netherlands|United Kingdom 1
Belgium|France|Ireland|Italy|Netherlands|Norway|Poland|Portugal|South Africa|Spain|United Kingdom 1
Bulgaria|Germany 1
Egypt 1
Finland 1
Israel|United States|Belgium|Canada|Germany|Italy|Spain 1
Italy|United States|Argentina|Australia|Brazil|Canada|Colombia|France|Germany|Ireland|Israel|Japan|Korea, Republic of|Mexico|New Zealand|Poland|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
Japan|Austria|Germany|Italy|Spain|Switzerland|United Kingdom 1
Korea, Republic of 1
Luxembourg 1
Netherlands|Norway|Poland 1
Saudi Arabia 1
Switzerland 1
Thailand 1
United Kingdom|United States|Belgium|Denmark|Sweden 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Germany|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|China|Colombia|Estonia|Germany|Greece|Hong Kong|Japan|Korea, Republic of|Poland|Russian Federation|Singapore 1
United States|Australia|Belgium|Brazil|Canada|France|Germany|Italy|Japan|Poland|Russian Federation|Singapore|Spain 1
United States|Australia|Belgium|Canada|Germany|Italy|Netherlands|Norway|Spain|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|Japan|Norway 1
United States|Australia|Canada|Norway|United Kingdom 1
United States|Australia|France|Spain 1
United States|Austria|Belarus|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Czechia|Denmark|Finland|Germany|Ireland|Israel|Italy|Netherlands|Norway|Poland|Romania|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Belarus|Belgium|Canada|Denmark|Finland|Hungary|Israel|Netherlands|Norway|Turkey 1
United States|Belgium 1
United States|Belgium|Bulgaria|Hungary|Poland|Romania|Russian Federation|Ukraine 1
United States|Belgium|Denmark|Hungary|United Kingdom 1
United States|Belgium|Denmark|Netherlands|Spain|United Kingdom 1
United States|Belgium|Finland|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Spain|Switzerland 1
United States|Belgium|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Belgium|United Kingdom 1
United States|Brazil|Italy|Korea, Republic of|New Zealand|Spain|United Kingdom 1
United States|Canada|Denmark|France|Italy|Japan|Netherlands|Singapore|Spain|United Kingdom 1
United States|Canada|Hong Kong 1
United States|Canada|Hong Kong|Singapore 1
United States|Canada|Hungary 1
United States|Canada|Japan 1
United States|Canada|Japan|Korea, Republic of 1
United States|Canada|Netherlands|Russian Federation 1
United States|Canada|Netherlands|Spain 1
United States|Canada|Puerto Rico 1
United States|Denmark 1
United States|Israel|Spain 1
United States|Italy 1
United States|Korea, Republic of 1
United States|Korea, Republic of|Poland|Russian Federation|Ukraine 1
United States|Netherlands|Spain|United Kingdom 1
United States|Norway 1
United States|Puerto Rico 1
United States|Spain 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 204
2 27
3 22
4 11
5 7
6 8
7 9
8 9
9 5
10 9
11 2
12 3
13 3
14 1
15 3
16 3
17 7
18 3
19 3
20 2
21 1
22 1
23 4
24 2
25 2
26 1
28 5
29 2
31 1
33 1
34 1
35 1
38 1
40 1
41 2
42 1
43 1
45 4
46 1
47 1
49 1
54 2
58 2
66 1
67 1
70 1
73 2
75 1
78 1
79 1
82 1
94 1
108 1
112 1
122 1
123 1
137 1
153 1
169 1
180 1
233 1
433 1
651 1
1329 1

Phase

Phase Study_Count
Phase 2 148
N/A 109
Phase 1 64
Phase 3 36
Phase 1/Phase 2 28
Early Phase 1 10
Phase 4 4
Phase 2/Phase 3 3

Number of Arms

Number_of_Arms Count_of_Studies
1 196
2 120
3 17
4 13
5 2
6 3
7 1
9 2
25 1
37 1
NA 46

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 2.00 10.0000 10.00000 2.00 5.0000 64 24.0000 30.0
1st Qu. 16.25 40.0000 19.50000 47.75 35.0000 144 197.5000 45.0
Median 22.50 89.5000 35.00000 116.00 50.0000 224 306.5000 60.0
Mean 60.30 190.6111 64.46032 209.75 115.1894 276 439.9412 362.5
3rd Qu. 82.00 222.5000 58.50000 208.50 76.0000 382 540.2500 377.5
Max. 278.00 1884.0000 500.00000 1732.00 6452.0000 540 2300.0000 1300.0

Trial Group Type

group_type Group_Count
Experimental 513
Active Comparator 76
NA 46
No Intervention 26
Other 25
Placebo Comparator 13
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 210
Parallel Assignment 141
NA 32
Sequential Assignment 15
Crossover Assignment 4

Primary Purpose

primary_purpose Study_Count
Treatment 299
Supportive Care 34
Diagnostic 29
Prevention 15
NA 7
Basic Science 5
Other 5
Screening 4
Health Services Research 3
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 41
United Kingdom 9
China 8
NA 6
Canada 5
Australia 3
France 3
Italy 3
Egypt 2
Spain 2
Taiwan 2
Turkey 2
Austria 1
Austria|Belgium|France|Germany|Greece|Italy|Netherlands|Poland|Romania 1
Belgium 1
Czechia 1
Germany 1
Hong Kong 1
Israel 1
Korea, Republic of 1
Martinique 1
Netherlands 1
Netherlands|Poland|Slovenia 1
Norway 1
Poland 1
Sweden 1
United States|Australia|Canada 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 80
2 6
3 1
4 1
5 2
6 1
7 2
8 3
10 2
12 1
44 1
111 1
118 1

Enrollment Metrics

Measure Observational
Min 6.00
1st Qu 76.50
Median 189.50
Mean 22846.80
3rd Qu 758.25
Max 1600000.00

Observation Model

observational_model Study_Count
Cohort 48
Case-Only 21
Case-Control 17
Case Control 7
NA 4
Other 3
Ecologic or Community 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 68
Retrospective 23
Cross-Sectional 6
NA 4
Other 1

Registries

Studies by Country

Country Study_Count
Denmark 2
United States 2
China 1
Taiwan 1
Turkey 1
United States|Australia|Austria|Belgium|Canada|China|Denmark|France|Germany|Ireland|Italy|Japan|Korea, Republic of|Netherlands|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 5
3 1
19 1
75 1

Enrollment Metrics

Measure Registries
Min 100.0
1st Qu 163.0
Median 260.0
Mean 126428.6
3rd Qu 3375.0
Max 999999.0

Registry Model

observational_model Study_Count
Cohort 6
Case-Only 2

Time Perspective

time_perspective Study_Count
Prospective 8

Follow-up

target_duration Study_Count
36 Months 2
12 Months 1
3 Years 1
4 Months 1
5 Years 1
6 Years 1
80 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03345485 Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03345485 Active, not recruiting Mundipharma-EDO GmbH 2021-12-31
NCT04456972 Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. https://ClinicalTrials.gov/show/NCT04456972 Recruiting Poitiers University Hospital 2021-06-16
NCT04214067 Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT04214067 Recruiting National Cancer Institute (NCI) 2024-02-01
NCT04205864 Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. https://ClinicalTrials.gov/show/NCT04205864 Completed Kocaeli University 2020-07-01
NCT04205630 SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT04205630 Recruiting Byondis B.V. 2022-04-30
NCT03324958 VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. https://ClinicalTrials.gov/show/NCT03324958 Recruiting Institut de Cancérologie de la Loire 2021-02-01
NCT03395080 A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma https://ClinicalTrials.gov/show/NCT03395080 Active, not recruiting Leap Therapeutics, Inc. 2020-06-30
NCT03394027 ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03394027 Recruiting National Institutes of Health Clinical Center (CC) 2022-08-01
NCT03372720 Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors https://ClinicalTrials.gov/show/NCT03372720 Active, not recruiting Ohio State University Comprehensive Cancer Center 2019-12-18
NCT03367923 Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors https://ClinicalTrials.gov/show/NCT03367923 Active, not recruiting Stanford University 2020-04-01
NCT03366480 A Study to Assess the Efficacy and Safety of ABTL0812 https://ClinicalTrials.gov/show/NCT03366480 Recruiting Ability Pharmaceuticals SL 2020-06-01
NCT03832361 Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer https://ClinicalTrials.gov/show/NCT03832361 Recruiting Yale University 2023-10-31
NCT03722030 Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors https://ClinicalTrials.gov/show/NCT03722030 Completed University of Wisconsin, Madison 2020-03-14
NCT03366051 Sentinel Node Mapping in High Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT03366051 Recruiting AC Camargo Cancer Center 2021-12-20
NCT03820024 MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback https://ClinicalTrials.gov/show/NCT03820024 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2019-12-23
NCT03339843 Multiorgan Metabolic Imaging Response Assessment of Abemaciclib https://ClinicalTrials.gov/show/NCT03339843 Recruiting Jules Bordet Institute 2021-10-15
NCT03339765 Self-Advocacy Serious Game in Advanced Cancer https://ClinicalTrials.gov/show/NCT03339765 Recruiting University of Pittsburgh 2022-04-30
NCT03314935 A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors https://ClinicalTrials.gov/show/NCT03314935 Recruiting Incyte Corporation 2021-10-06
NCT03300557 Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer https://ClinicalTrials.gov/show/NCT03300557 Recruiting National Cancer Institute (NCI) 2021-12-01
NCT03285152 A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT03285152 Recruiting Memorial Sloan Kettering Cancer Center 2021-08-11
NCT03277482 Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer https://ClinicalTrials.gov/show/NCT03277482 Recruiting Dana-Farber Cancer Institute 2021-01-01
NCT03276013 Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT03276013 Active, not recruiting Vall d’Hebron Institute of Oncology 2020-06-01
NCT03270995 Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study https://ClinicalTrials.gov/show/NCT03270995 Completed McGill University 2020-02-01
NCT03245736 Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. https://ClinicalTrials.gov/show/NCT03245736 Completed Genmab 2019-01-10
NCT03241914 Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer https://ClinicalTrials.gov/show/NCT03241914 Recruiting Fudan University 2020-07-03
NCT03241745 A Study of Nivolumab in Selected Uterine Cancer Patients https://ClinicalTrials.gov/show/NCT03241745 Recruiting Memorial Sloan Kettering Cancer Center 2021-08-31
NCT03212404 Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers https://ClinicalTrials.gov/show/NCT03212404 Recruiting Checkpoint Therapeutics, Inc. 2021-07-31
NCT03210129 Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients https://ClinicalTrials.gov/show/NCT03210129 Completed Luxembourg Institute of Health 2019-02-28
NCT03207126 Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? https://ClinicalTrials.gov/show/NCT03207126 Recruiting Imperial College London 2020-12-20
NCT03207074 Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? https://ClinicalTrials.gov/show/NCT03207074 Completed Imperial College London 2019-06-20
NCT03207061 Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? https://ClinicalTrials.gov/show/NCT03207061 Recruiting Imperial College London 2020-12-01
NCT03192059 Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer https://ClinicalTrials.gov/show/NCT03192059 Recruiting University Hospital, Ghent 2021-06-30
NCT03189446 Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer https://ClinicalTrials.gov/show/NCT03189446 Active, not recruiting University of Oklahoma 2022-06-01
NCT03184350 Adjuvant Protontherapy of Cervical and Endometrial Carcinomas https://ClinicalTrials.gov/show/NCT03184350 Recruiting Heidelberg University 2019-06-30
NCT03171506 Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification https://ClinicalTrials.gov/show/NCT03171506 Completed University of Alabama at Birmingham 2017-07-18
NCT03170960 Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT03170960 Recruiting Exelixis 2020-12-31
NCT03149549 PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors https://ClinicalTrials.gov/show/NCT03149549 Recruiting CytomX Therapeutics 2019-12-31
NCT03120624 VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT03120624 Recruiting Mayo Clinic 2020-06-01
NCT03099499 Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT03099499 Recruiting Fox Chase Cancer Center 2021-10-01
NCT03095664 Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors https://ClinicalTrials.gov/show/NCT03095664 Recruiting Brazilian National Cancer Institute 2023-11-30
NCT03077698 An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT03077698 Active, not recruiting Xenetic Biosciences, Inc. 2021-01-31
NCT03042897 Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer https://ClinicalTrials.gov/show/NCT03042897 Recruiting University of Southern California 2020-09-08
NCT03015129 A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer https://ClinicalTrials.gov/show/NCT03015129 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-01-31
NCT03008408 Study of Ribociclib (LEE011), Everolimus, and Letrozole, in Patients With Advanced or Recurrent Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03008408 Recruiting M.D. Anderson Cancer Center 2022-08-31
NCT02997553 Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery https://ClinicalTrials.gov/show/NCT02997553 Recruiting Institut de Cancérologie de Lorraine 2022-11-30
NCT02988817 Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT02988817 Recruiting Genmab 2021-02-28
NCT02987881 Endometrial Cancer Diet and Exercise https://ClinicalTrials.gov/show/NCT02987881 Completed Duke University 2019-06-01
NCT02983279 Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer https://ClinicalTrials.gov/show/NCT02983279 Active, not recruiting Thomas Jefferson University 2021-10-27
NCT02977195 First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT02977195 Recruiting Centre Leon Berard 2020-11-30
NCT02914470 Carboplatin-cyclophosphamide Combined With Atezolizumab https://ClinicalTrials.gov/show/NCT02914470 Active, not recruiting The Netherlands Cancer Institute 2017-08-31
NCT02912572 Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT02912572 Recruiting Dana-Farber Cancer Institute 2021-10-31
NCT02899793 Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer https://ClinicalTrials.gov/show/NCT02899793 Active, not recruiting Yale University 2020-12-31
NCT02807844 Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies https://ClinicalTrials.gov/show/NCT02807844 Active, not recruiting Novartis 2020-04-28
NCT02788708 Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer https://ClinicalTrials.gov/show/NCT02788708 Active, not recruiting Ohio State University Comprehensive Cancer Center 2019-11-30
NCT02774759 Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers https://ClinicalTrials.gov/show/NCT02774759 Active, not recruiting M.D. Anderson Cancer Center 2020-10-31
NCT02755844 Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT02755844 Active, not recruiting Hospices Civils de Lyon 2018-11-30
NCT02744898 A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus https://ClinicalTrials.gov/show/NCT02744898 Active, not recruiting NYU Langone Health 2018-08-17
NCT02730923 Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) https://ClinicalTrials.gov/show/NCT02730923 Recruiting Centre Leon Berard 2019-11-30
NCT02730429 Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT02730429 Active, not recruiting Nordic Society of Gynaecological Oncology - Clinical Trials Unit 2018-12-15
NCT02730416 Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer https://ClinicalTrials.gov/show/NCT02730416 Active, not recruiting Nordic Society of Gynaecological Oncology - Clinical Trials Unit 2019-03-31
NCT02728830 A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers https://ClinicalTrials.gov/show/NCT02728830 Active, not recruiting Duke University 2019-01-31
NCT02725489 Pilot Study of Durvalumab and Vigil in Advanced Women’s Cancers https://ClinicalTrials.gov/show/NCT02725489 Active, not recruiting Mary Crowley Medical Research Center 2019-12-30
NCT02725268 A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer https://ClinicalTrials.gov/show/NCT02725268 Active, not recruiting Takeda 2019-07-02
NCT02714621 MR-HIFU for Recurrent Gynaecological Cancer https://ClinicalTrials.gov/show/NCT02714621 Recruiting Institute of Cancer Research, United Kingdom 2020-03-31
NCT02690766 Translating Healthy Lifestyle Interventions for Cancer Survivors https://ClinicalTrials.gov/show/NCT02690766 Completed University of North Carolina, Chapel Hill 2016-05-31
NCT02684227 Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer https://ClinicalTrials.gov/show/NCT02684227 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT02676726 STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer https://ClinicalTrials.gov/show/NCT02676726 Completed Hospital Universitari Vall d’Hebron Research Institute 2019-09-30
NCT02658565 Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation https://ClinicalTrials.gov/show/NCT02658565 Recruiting University of Kentucky 2020-12-31
NCT02657928 Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer https://ClinicalTrials.gov/show/NCT02657928 Active, not recruiting Mayo Clinic 2018-05-21
NCT02646748 Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02646748 Active, not recruiting Incyte Corporation 2019-11-07
NCT02646319 Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations https://ClinicalTrials.gov/show/NCT02646319 Completed Mayo Clinic 2017-09-05
NCT02630823 MK-3475 Immunotherapy in Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT02630823 Active, not recruiting Washington University School of Medicine 2019-01-01
NCT02622776 Advanced Methods for Cancer Detection by Vaginal Screening https://ClinicalTrials.gov/show/NCT02622776 Completed British Columbia Cancer Agency 2018-08-31
NCT02611024 Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Patients With Selected Solid Tumors https://ClinicalTrials.gov/show/NCT02611024 Recruiting PharmaMar 2020-11-30
NCT02598219 Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. https://ClinicalTrials.gov/show/NCT02598219 Active, not recruiting Centre Oscar Lambret 2021-11-30
NCT02584478 Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) https://ClinicalTrials.gov/show/NCT02584478 Recruiting Advenchen Laboratories, LLC 2020-12-31
NCT01977274 Predictive Clinical and Biological Parameters in Gynecological Cancer https://ClinicalTrials.gov/show/NCT01977274 Recruiting Institut Paoli-Calmettes 2023-12-31
NCT02575872 Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors https://ClinicalTrials.gov/show/NCT02575872 Completed Albert Einstein College of Medicine 2018-04-30
NCT02767362 A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium https://ClinicalTrials.gov/show/NCT02767362 Completed UNC Lineberger Comprehensive Cancer Center 2019-09-26
NCT02632448 A Study of LY2880070 in Participants With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT02632448 Recruiting Esperas Pharma Inc. 2020-03-27
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) https://ClinicalTrials.gov/show/NCT02465060 Recruiting National Cancer Institute (NCI) 2022-06-30
NCT02269293 Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers https://ClinicalTrials.gov/show/NCT02269293 Recruiting Memorial Sloan Kettering Cancer Center 2021-10-31
NCT02564276 Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer https://ClinicalTrials.gov/show/NCT02564276 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2017-04-30
NCT02560571 Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT02560571 Recruiting Meir Medical Center 2020-10-31
NCT02552121 Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT02552121 Completed Genmab 2017-12-13
NCT02549989 Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT02549989 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-09-30
NCT02549209 Pembro/Carbo/Taxol in Endometrial Cancer https://ClinicalTrials.gov/show/NCT02549209 Recruiting Big Ten Cancer Research Consortium 2019-12-01
NCT02543710 Biomarker Guided Treatment in Gynaecological Cancer https://ClinicalTrials.gov/show/NCT02543710 Recruiting Haukeland University Hospital 2020-12-31
NCT02494791 Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer https://ClinicalTrials.gov/show/NCT02494791 Active, not recruiting University Health Network, Toronto 2020-07-31
NCT02476955 Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole https://ClinicalTrials.gov/show/NCT02476955 Active, not recruiting ArQule 2020-12-31
NCT02433626 Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies https://ClinicalTrials.gov/show/NCT02433626 Recruiting Critical Outcome Technologies Inc. 2019-12-31
NCT02433080 Diet and Physical Activity in Uterine Cancer Survivors https://ClinicalTrials.gov/show/NCT02433080 Completed University College, London 2015-12-31
NCT02431676 Survivorship Promotion In Reducing IGF-1 Trial https://ClinicalTrials.gov/show/NCT02431676 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2018-12-31
NCT02413606 ENdometrial Cancer SURvivors’ Follow-up carE (ENSURE): Less is More? https://ClinicalTrials.gov/show/NCT02413606 Recruiting Comprehensive Cancer Centre The Netherlands 2021-03-31
NCT02397083 Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer https://ClinicalTrials.gov/show/NCT02397083 Recruiting M.D. Anderson Cancer Center 2026-09-30
NCT02393248 Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) https://ClinicalTrials.gov/show/NCT02393248 Recruiting Incyte Corporation 2020-07-31
NCT02387645 LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT02387645 Completed Medical University of Vienna 2017-05-31
NCT02351479 Hula, a Physical Activity Intervention for Female-Cancer Survivors https://ClinicalTrials.gov/show/NCT02351479 Completed University of Hawaii 2017-12-31
NCT02342730 Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia https://ClinicalTrials.gov/show/NCT02342730 Completed Case Comprehensive Cancer Center 2015-05-18
NCT02320565 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial https://ClinicalTrials.gov/show/NCT02320565 Completed Catholic University of the Sacred Heart 2015-03-31
NCT02285192 Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer https://ClinicalTrials.gov/show/NCT02285192 Recruiting Memorial Sloan Kettering Cancer Center 2020-11-30
NCT02262455 Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02262455 Completed Santa Maria Biotherapeutics 2017-01-13
NCT02228681 Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer https://ClinicalTrials.gov/show/NCT02228681 Active, not recruiting Gynecologic Oncology Group 2018-01-31
NCT02221076 Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. https://ClinicalTrials.gov/show/NCT02221076 Completed Mauna Kea Technologies 2016-04-18
NCT02209532 A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping https://ClinicalTrials.gov/show/NCT02209532 Completed Novadaq Technologies ULC, now a part of Stryker 2017-06-30
NCT02178722 Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers https://ClinicalTrials.gov/show/NCT02178722 Active, not recruiting Incyte Corporation 2018-11-26
NCT02135562 Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors https://ClinicalTrials.gov/show/NCT02135562 Completed Case Comprehensive Cancer Center 2017-04-19
NCT02096783 Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer https://ClinicalTrials.gov/show/NCT02096783 Completed University of Wisconsin, Madison 2015-06-30
NCT02093598 POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus https://ClinicalTrials.gov/show/NCT02093598 Completed MedSIR 2014-03-31
NCT02091050 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy https://ClinicalTrials.gov/show/NCT02091050 Completed AC Camargo Cancer Center 2015-03-31
NCT02069158 Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor https://ClinicalTrials.gov/show/NCT02069158 Completed Oncology Institute of Southern Switzerland 2019-05-31
NCT02068820 Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG https://ClinicalTrials.gov/show/NCT02068820 Completed AdventHealth 2015-01-31
NCT02065687 Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT02065687 Active, not recruiting Gynecologic Oncology Group 2019-09-01
NCT02058550 Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy https://ClinicalTrials.gov/show/NCT02058550 Active, not recruiting Stanford University 2019-01-31
NCT01307631 Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer https://ClinicalTrials.gov/show/NCT01307631 Completed National Cancer Institute (NCI) 2016-01-31
NCT01289041 BKM120 as Second-line Therapy for Advanced Endometrial Cancer https://ClinicalTrials.gov/show/NCT01289041 Completed Novartis 2014-03-31
NCT01271764 The Association of G9a Protein and Outcome of Patients With Endometrial Cancer https://ClinicalTrials.gov/show/NCT01271764 Completed Far Eastern Memorial Hospital 2012-07-31
NCT02040155 Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy https://ClinicalTrials.gov/show/NCT02040155 Completed Duke University 2015-08-31
NCT04453904 Modality of Adjuvant Radiotherapy and Chemotherapy for Stage â…¢ Endometrial Cancer https://ClinicalTrials.gov/show/NCT04453904 Recruiting Peking University People’s Hospital 2025-04-30
NCT03603184 Atezolizumab Trial in Endometrial Cancer - AtTEnd https://ClinicalTrials.gov/show/NCT03603184 Recruiting Mario Negri Institute for Pharmacological Research 2021-07-31
NCT03526432 Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer https://ClinicalTrials.gov/show/NCT03526432 Recruiting University of Oklahoma 2021-05-25
NCT02017353 Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT02017353 Completed University Hospital, Gasthuisberg 2016-05-31
NCT02001623 Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT02001623 Completed Genmab 2019-05-02
NCT02025985 Phase II Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies & Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT02025985 Completed Karyopharm Therapeutics Inc 2017-02-13
NCT01979003 A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion https://ClinicalTrials.gov/show/NCT01979003 Active, not recruiting University of Arkansas 2020-10-31
NCT01965080 Exemestane in Advanced and Recurrent Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT01965080 Completed Nordic Society of Gynaecological Oncology - Clinical Trials Unit 2009-02-28
NCT01935973 Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT01935973 Active, not recruiting National Cancer Institute (NCI) 2017-02-01
NCT01935934 Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT01935934 Active, not recruiting National Cancer Institute (NCI) 2019-09-12
NCT01922778 Screening for Endometrial Abnormalities in Overweight and Obese Women https://ClinicalTrials.gov/show/NCT01922778 Completed St. Luke’s-Roosevelt Hospital Center 2016-03-31
NCT01911247 Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer https://ClinicalTrials.gov/show/NCT01911247 Completed UNC Lineberger Comprehensive Cancer Center 2013-02-28
NCT01908504 Adaptive Pet Study https://ClinicalTrials.gov/show/NCT01908504 Completed Duke University 2016-09-30
NCT01886066 Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT01886066 Active, not recruiting University Health Network, Toronto 2020-05-31
NCT01870947 Assisted Exercise in Obese Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT01870947 Completed Case Comprehensive Cancer Center 2019-09-04
NCT01847703 Robotic Versus Abdominal Surgery for Endometrial Cancer https://ClinicalTrials.gov/show/NCT01847703 Completed Karolinska Institutet 2016-07-31
NCT01820884 The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT01820884 Recruiting Huazhong University of Science and Technology 2020-12-31
NCT01820858 The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT01820858 Recruiting Huazhong University of Science and Technology 2019-04-30
NCT01818739 Lymph Node Mapping in Patients With Endometrial Cancer https://ClinicalTrials.gov/show/NCT01818739 Completed Ohio State University Comprehensive Cancer Center 2016-11-16
NCT01810874 STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer https://ClinicalTrials.gov/show/NCT01810874 Completed Hospital Universitari Vall d’Hebron Research Institute 2014-07-31
NCT01797523 A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT01797523 Active, not recruiting M.D. Anderson Cancer Center 2020-10-31
NCT01767155 Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer https://ClinicalTrials.gov/show/NCT01767155 Completed AEterna Zentaris 2017-01-30
NCT01764802 Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer https://ClinicalTrials.gov/show/NCT01764802 Completed Ohio State University Comprehensive Cancer Center 2017-06-01
NCT01764789 Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer https://ClinicalTrials.gov/show/NCT01764789 Completed Ohio State University Comprehensive Cancer Center 2012-01-31
NCT01738152 Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health https://ClinicalTrials.gov/show/NCT01738152 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-11-30
NCT01737619 PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT01737619 Active, not recruiting M.D. Anderson Cancer Center 2020-04-30
NCT01717391 [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers https://ClinicalTrials.gov/show/NCT01717391 Completed University of Iowa 2016-02-29
NCT01705288 Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study https://ClinicalTrials.gov/show/NCT01705288 Completed Masonic Cancer Center, University of Minnesota 2016-08-24
NCT01697566 An Endometrial Cancer Chemoprevention Study of Metformin https://ClinicalTrials.gov/show/NCT01697566 Active, not recruiting M.D. Anderson Cancer Center 2021-09-30
NCT01689714 Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT01689714 Completed Endocyte NA
NCT01686256 Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer https://ClinicalTrials.gov/show/NCT01686256 Completed Endocyte 2004-08-31
NCT01673022 Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging https://ClinicalTrials.gov/show/NCT01673022 Completed Indiana University 2017-01-31
NCT01652794 Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer https://ClinicalTrials.gov/show/NCT01652794 Completed Case Comprehensive Cancer Center 2014-05-31
NCT03349463 Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. https://ClinicalTrials.gov/show/NCT03349463 Recruiting Loyola University 2020-12-31
NCT01631552 Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers https://ClinicalTrials.gov/show/NCT01631552 Active, not recruiting Immunomedics, Inc. 2020-06-30
NCT01610375 Telephone Follow-up After Treatment for Endometrial Cancer https://ClinicalTrials.gov/show/NCT01610375 Completed Queensland Centre for Gynaecological Cancer 2014-03-31
NCT01588522 Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease https://ClinicalTrials.gov/show/NCT01588522 Completed Berg, LLC 2017-01-31
NCT01580696 Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer https://ClinicalTrials.gov/show/NCT01580696 Completed San Antonio Military Medical Center 2016-07-31
NCT01562106 Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery https://ClinicalTrials.gov/show/NCT01562106 Completed Swedish Medical Center 2015-09-30
NCT01549782 Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy. https://ClinicalTrials.gov/show/NCT01549782 Completed Hospital General Universitario Gregorio Marañon 2007-12-31
NCT01526655 Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer https://ClinicalTrials.gov/show/NCT01526655 Completed University Hospital, Linkoeping 2016-07-27
NCT01523678 Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers https://ClinicalTrials.gov/show/NCT01523678 Completed Belgian Gynaecological Oncology Group 2014-05-31
NCT01512810 Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer https://ClinicalTrials.gov/show/NCT01512810 Active, not recruiting University of Kentucky 2020-07-28
NCT01482728 Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer https://ClinicalTrials.gov/show/NCT01482728 Completed University of Virginia 2015-05-31
NCT01470677 Tachosil for the Prevention of Symptomatic Lymph Cysts https://ClinicalTrials.gov/show/NCT01470677 Completed Ruhr University of Bochum 2016-01-31
NCT01467219 Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer https://ClinicalTrials.gov/show/NCT01467219 Completed University Health Network, Toronto 2014-03-31
NCT01466777 Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy https://ClinicalTrials.gov/show/NCT01466777 Active, not recruiting Tampere University Hospital 2019-08-31
NCT01460979 Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT01460979 Completed AGO Study Group 2015-06-30
NCT01455493 A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT01455493 Completed Genentech, Inc. 2013-03-31
NCT01440998 Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT01440998 Completed National Cancer Institute (NCI) 2015-12-31
NCT01397877 GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT01397877 Completed ARCAGY/ GINECO GROUP 2014-10-31
NCT01379534 A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT01379534 Completed Novartis 2014-03-31
NCT01367002 Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer https://ClinicalTrials.gov/show/NCT01367002 Active, not recruiting Yale University 2020-12-31
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction https://ClinicalTrials.gov/show/NCT01366144 Active, not recruiting National Cancer Institute (NCI) 2017-11-10
NCT01364844 Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors https://ClinicalTrials.gov/show/NCT01364844 Completed Daiichi Sankyo, Inc. 2013-11-30
NCT04438564 Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients https://ClinicalTrials.gov/show/NCT04438564 Recruiting China Medical University Hospital 2021-12-31
NCT04295109 Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function https://ClinicalTrials.gov/show/NCT04295109 Recruiting The First Affiliated Hospital with Nanjing Medical University 2020-07-31
NCT04291105 Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients https://ClinicalTrials.gov/show/NCT04291105 Recruiting Vyriad, Inc. 2022-03-31
NCT04276532 Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus https://ClinicalTrials.gov/show/NCT04276532 Recruiting Fudan University 2025-01-10
NCT04302714 Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer https://ClinicalTrials.gov/show/NCT04302714 Completed Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2019-03-28
NCT04269200 Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT04269200 Recruiting AstraZeneca 2023-06-05
NCT04251416 A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT04251416 Recruiting Yale University 2024-02-29
NCT04235179 Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer https://ClinicalTrials.gov/show/NCT04235179 Recruiting King Saud University 2022-01-31
NCT04224467 The Application of Real-Time Near-infrared Imaging in Gynecological Surgery https://ClinicalTrials.gov/show/NCT04224467 Recruiting Southern Medical University, China 2024-11-30
NCT04212377 Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT04212377 Recruiting Radboud University 2022-02-28
NCT04188548 A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer https://ClinicalTrials.gov/show/NCT04188548 Recruiting Eli Lilly and Company 2022-10-28
NCT04157491 Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer https://ClinicalTrials.gov/show/NCT04157491 Recruiting Sun Yat-sen University 2020-12-31
NCT04152018 Study of PF‑06940434 in Patients With Advanced or Metastatic Solid Tumors. https://ClinicalTrials.gov/show/NCT04152018 Recruiting Pfizer 2024-03-02
NCT04149691 Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies https://ClinicalTrials.gov/show/NCT04149691 Recruiting Celon Pharma SA 2020-07-31
NCT04122235 The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study https://ClinicalTrials.gov/show/NCT04122235 Recruiting Sorlandet Hospital HF 2024-12-31
NCT04106414 Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment https://ClinicalTrials.gov/show/NCT04106414 Recruiting Memorial Sloan Kettering Cancer Center 2021-09-30
NCT04080284 Trial of Maintenance With Niraparib- Uterine Serous Carcinoma https://ClinicalTrials.gov/show/NCT04080284 Recruiting Northwell Health 2022-07-01
NCT04068675 Effects of Centering Pre-operative Counseling on Patient Reported Anxiety https://ClinicalTrials.gov/show/NCT04068675 Recruiting Northwestern University 2020-06-30
NCT04025229 High Intensity Interval Training in Endometrial Cancer https://ClinicalTrials.gov/show/NCT04025229 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2021-05-20
NCT04021459 Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery. https://ClinicalTrials.gov/show/NCT04021459 Recruiting University Hospital, Montpellier 2020-09-02
NCT04014530 Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study https://ClinicalTrials.gov/show/NCT04014530 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2021-08-01
NCT03983954 Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT03983954 Recruiting NeoTX Therapeutics Ltd. 2021-11-01
NCT03968406 Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers https://ClinicalTrials.gov/show/NCT03968406 Recruiting M.D. Anderson Cancer Center 2021-10-11
NCT03955978 TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer https://ClinicalTrials.gov/show/NCT03955978 Recruiting Washington University School of Medicine 2022-03-31
NCT03951415 Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT03951415 Recruiting Leiden University Medical Center 2023-07-01
NCT03935282 Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors https://ClinicalTrials.gov/show/NCT03935282 Enrolling by invitation Wake Forest University Health Sciences 2023-05-31
NCT03935256 Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT03935256 Recruiting Loyola University 2021-03-31
NCT03924245 Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers https://ClinicalTrials.gov/show/NCT03924245 Recruiting Vanderbilt-Ingram Cancer Center 2023-09-30
NCT03917381 GEN1046 Safety Trial in Patients With Malignant Solid Tumors https://ClinicalTrials.gov/show/NCT03917381 Recruiting Genmab 2021-10-31
NCT03909152 A Study of Onapristone ER in Low Grade Serous Ovarian Cancer and Other Progesterone Receptor Positive Gynecologic Cancers https://ClinicalTrials.gov/show/NCT03909152 Recruiting Memorial Sloan Kettering Cancer Center 2021-04-30
NCT03908996 the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer https://ClinicalTrials.gov/show/NCT03908996 Recruiting Sanford Health 2020-04-15
NCT03900104 Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer https://ClinicalTrials.gov/show/NCT03900104 Completed Kocaeli University 2020-01-01
NCT03899441 Multimedia Aid Gynecologic Counseling and Consent https://ClinicalTrials.gov/show/NCT03899441 Recruiting UNC Lineberger Comprehensive Cancer Center 2020-04-01
NCT03896113 Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03896113 Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2022-06-30
NCT03876860 An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis https://ClinicalTrials.gov/show/NCT03876860 Recruiting Loyola University 2021-04-01
NCT03827837 Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors https://ClinicalTrials.gov/show/NCT03827837 Recruiting Jiangsu HengRui Medicine Co., Ltd. 2020-06-30
NCT03787056 Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients https://ClinicalTrials.gov/show/NCT03787056 Recruiting Hospices Civils de Lyon 2026-11-30
NCT03785288 Vaginal Cuff Brachytherapy Fractionation Study https://ClinicalTrials.gov/show/NCT03785288 Recruiting University of Virginia 2022-01-01
NCT03778255 Sentinel Lymph Node Mapping In Endometrial Cancer https://ClinicalTrials.gov/show/NCT03778255 Recruiting Peking University People’s Hospital 2020-06-30
NCT03776630 Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors https://ClinicalTrials.gov/show/NCT03776630 Recruiting Assistance Publique - Hôpitaux de Paris 2022-05-31
NCT03752606 Application of Tachosil During Lymphadenectomy https://ClinicalTrials.gov/show/NCT03752606 Completed Medical University of Lublin 2014-12-31
NCT03752398 A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) https://ClinicalTrials.gov/show/NCT03752398 Recruiting Xencor, Inc. 2024-09-30
NCT03748186 Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers https://ClinicalTrials.gov/show/NCT03748186 Recruiting Sutro Biopharma, Inc. 2022-08-31
NCT03698604 Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial Neoplasia https://ClinicalTrials.gov/show/NCT03698604 Completed Ain Shams Maternity Hospital 2018-05-01
NCT03694262 The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) https://ClinicalTrials.gov/show/NCT03694262 Recruiting Medical College of Wisconsin 2021-06-28
NCT03675893 Abemaciclib With Letrozole in Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT03675893 Recruiting Dana-Farber Cancer Institute 2021-05-01
NCT03671811 Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy https://ClinicalTrials.gov/show/NCT03671811 Recruiting City of Hope Medical Center 2020-12-07
NCT03667716 COM701 in Subjects With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03667716 Recruiting Compugen Ltd 2021-06-30
NCT03653819 High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs https://ClinicalTrials.gov/show/NCT03653819 Completed Herlev and Gentofte Hospital 2018-11-13
NCT03629756 A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies https://ClinicalTrials.gov/show/NCT03629756 Recruiting Arcus Biosciences, Inc. 2021-01-31
NCT03618472 Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells https://ClinicalTrials.gov/show/NCT03618472 Completed Rajavithi Hospital 2019-11-30
NCT03617679 Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT03617679 Recruiting University of Colorado, Denver 2021-09-30
NCT03611517 Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer https://ClinicalTrials.gov/show/NCT03611517 Recruiting Leiden University Medical Center 2022-07-31
NCT03595722 Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers https://ClinicalTrials.gov/show/NCT03595722 Recruiting Imperial College London 2022-08-28
NCT03586661 Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer https://ClinicalTrials.gov/show/NCT03586661 Recruiting M.D. Anderson Cancer Center 2021-04-30
NCT03580421 Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO) https://ClinicalTrials.gov/show/NCT03580421 Recruiting Assistance Publique - Hôpitaux de Paris 2021-08-01
NCT03572478 Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer https://ClinicalTrials.gov/show/NCT03572478 Active, not recruiting University of Chicago 2020-02-29
NCT03570437 Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? https://ClinicalTrials.gov/show/NCT03570437 Recruiting University of Manchester 2021-01-31
NCT03555422 Maintenance With Selinexor/Placebo After Combination Chemotherapy in Endometrial Cancer [SIENDO] https://ClinicalTrials.gov/show/NCT03555422 Recruiting Karyopharm Therapeutics Inc 2023-03-31
NCT03538704 Effect of Fertility-sparing Therapy of Early Endometrial Cancer https://ClinicalTrials.gov/show/NCT03538704 Recruiting Peking University People’s Hospital 2020-03-31
NCT03538028 A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies https://ClinicalTrials.gov/show/NCT03538028 Recruiting Incyte Corporation 2020-09-24
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03517488 Recruiting Xencor, Inc. 2020-12-31
NCT03517449 Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician’s Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) https://ClinicalTrials.gov/show/NCT03517449 Active, not recruiting Eisai Inc. 2022-02-24
NCT03514121 FPA150 in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03514121 Active, not recruiting Five Prime Therapeutics, Inc. 2023-01-31
NCT03508570 Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis https://ClinicalTrials.gov/show/NCT03508570 Recruiting M.D. Anderson Cancer Center 2021-01-01
NCT03485729 ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer https://ClinicalTrials.gov/show/NCT03485729 Recruiting Oncoceutics, Inc. 2020-03-21
NCT03476798 Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium https://ClinicalTrials.gov/show/NCT03476798 Active, not recruiting University of Oklahoma 2020-05-12
NCT03469674 PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer https://ClinicalTrials.gov/show/NCT03469674 Recruiting Leiden University Medical Center 2026-12-31
NCT03466788 Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer https://ClinicalTrials.gov/show/NCT03466788 Completed Centre Francois Baclesse 2019-03-28
NCT03463252 Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC https://ClinicalTrials.gov/show/NCT03463252 Recruiting West China Second University Hospital 2019-12-30
NCT03456908 F-18 TFB-PET Studies in Cancer Patients Undergoing NIS-containing Viral Therapies https://ClinicalTrials.gov/show/NCT03456908 Completed Mayo Clinic 2019-12-31
NCT03454451 CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers https://ClinicalTrials.gov/show/NCT03454451 Recruiting Corvus Pharmaceuticals, Inc. 2022-03-31
NCT03438474 Endometrial Cancer Lymphadenectomy Trial https://ClinicalTrials.gov/show/NCT03438474 Recruiting Philipps University Marburg Medical Center 2028-02-15
NCT03422198 Short Course Vaginal Cuff Brachytherapy in Treating Patients With Stage I-II Endometrial Cancer https://ClinicalTrials.gov/show/NCT03422198 Recruiting University of Utah 2022-01-08
NCT01262040 Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive https://ClinicalTrials.gov/show/NCT01262040 Completed Memorial Sloan Kettering Cancer Center 2018-10-29
NCT01256268 Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids https://ClinicalTrials.gov/show/NCT01256268 Completed H. Lee Moffitt Cancer Center and Research Institute 2016-02-03
NCT01244789 Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT01244789 Active, not recruiting Danish Gynecological Cancer Group 2019-04-15
NCT01237067 Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers https://ClinicalTrials.gov/show/NCT01237067 Completed National Institutes of Health Clinical Center (CC) 2014-11-16
NCT01226316 Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules https://ClinicalTrials.gov/show/NCT01226316 Active, not recruiting AstraZeneca 2019-04-26
NCT01209195 A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers https://ClinicalTrials.gov/show/NCT01209195 Completed Merrimack Pharmaceuticals 2014-05-31
NCT01205672 Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer https://ClinicalTrials.gov/show/NCT01205672 Completed M.D. Anderson Cancer Center 2017-05-28
NCT01198184 Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT01198184 Completed National Cancer Institute (NCI) 2013-07-31
NCT01185626 ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers https://ClinicalTrials.gov/show/NCT01185626 Completed University of Tilburg 2016-07-31
NCT01155258 Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT01155258 Completed University of Southern California 2013-01-31
NCT01111461 Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression https://ClinicalTrials.gov/show/NCT01111461 Completed Eisai Inc. 2012-05-31
NCT01079832 Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies https://ClinicalTrials.gov/show/NCT01079832 Completed Case Comprehensive Cancer Center 2012-05-31
NCT01068483 Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients https://ClinicalTrials.gov/show/NCT01068483 Completed Novartis 2011-09-30
NCT01068249 Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT01068249 Active, not recruiting M.D. Anderson Cancer Center 2021-04-30
NCT01065662 AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies https://ClinicalTrials.gov/show/NCT01065662 Active, not recruiting Dana-Farber Cancer Institute 2013-09-30
NCT01045187 Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer https://ClinicalTrials.gov/show/NCT01045187 Completed Xoft, Inc. 2010-01-31
NCT01013324 Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT01013324 Completed Sanofi 2013-03-31
NCT01005329 Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer https://ClinicalTrials.gov/show/NCT01005329 Completed National Cancer Institute (NCI) 2012-06-30
NCT00997373 Letrozole as a Treatment of Endometrial Cancer https://ClinicalTrials.gov/show/NCT00997373 Completed University of California, Davis 2013-09-30
NCT00987051 Sentinel Node and Endometrial Cancer https://ClinicalTrials.gov/show/NCT00987051 Completed Assistance Publique - Hôpitaux de Paris 2009-12-31
NCT00977574 Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00977574 Active, not recruiting National Cancer Institute (NCI) 2015-01-31
NCT00924027 A Study of Patients Receiving High-Dose Rate Brachytherapy https://ClinicalTrials.gov/show/NCT00924027 Recruiting National Institutes of Health Clinical Center (CC) 2024-11-01
NCT00916708 Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients https://ClinicalTrials.gov/show/NCT00916708 Active, not recruiting Azienda Ospedaliera San Giovanni Battista 2018-07-31
NCT00910091 The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00910091 Completed Ipsen 2012-01-31
NCT00879359 Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer https://ClinicalTrials.gov/show/NCT00879359 Completed The Cleveland Clinic 2012-02-29
NCT00870337 Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT00870337 Completed ARCAGY/ GINECO GROUP 2011-05-31
NCT00859768 The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients https://ClinicalTrials.gov/show/NCT00859768 Completed Netherlands Open University 2010-10-31
NCT00842452 Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00842452 Completed Case Comprehensive Cancer Center 2011-04-30
NCT04237090 Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel https://ClinicalTrials.gov/show/NCT04237090 Recruiting Ciusss de L’Est de l’ÃŽle de Montréal 2020-09-30
NCT03932409 Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT03932409 Recruiting University of Oklahoma 2022-08-31
NCT02466061 TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors https://ClinicalTrials.gov/show/NCT02466061 Completed Fred Hutchinson Cancer Research Center 2016-06-30
NCT01679483 Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer https://ClinicalTrials.gov/show/NCT01679483 Completed Asan Medical Center 2015-11-30
NCT01918124 A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT01918124 Completed Fudan University 2013-01-31
NCT03835819 A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) https://ClinicalTrials.gov/show/NCT03835819 Recruiting Dana-Farber Cancer Institute 2021-10-01
NCT02465541 Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors https://ClinicalTrials.gov/show/NCT02465541 Active, not recruiting Ohio State University Comprehensive Cancer Center 2014-06-10
NCT01672892 Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer https://ClinicalTrials.gov/show/NCT01672892 Active, not recruiting Radiation Therapy Oncology Group 2015-12-31
NCT03981796 A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer https://ClinicalTrials.gov/show/NCT03981796 Recruiting Tesaro, Inc. 2021-10-11
NCT03169023 Scale Down for Endometrial Cancer https://ClinicalTrials.gov/show/NCT03169023 Completed Washington University School of Medicine 2019-02-03
NCT03016338 Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT03016338 Recruiting University Health Network, Toronto 2022-03-31
NCT02690259 Sentinel Lymph Node Detection in Endometrial Cancer https://ClinicalTrials.gov/show/NCT02690259 Completed Region Skane 2018-05-30
NCT03884101 Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) https://ClinicalTrials.gov/show/NCT03884101 Recruiting Merck Sharp & Dohme Corp. 2023-04-10
NCT03694834 Window of Opportunity Study of Pembrolizumab in Early Stage, High Grade Obesity-driven Endometrial Cancer https://ClinicalTrials.gov/show/NCT03694834 Recruiting UNC Lineberger Comprehensive Cancer Center 2022-05-01
NCT02035787 Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients https://ClinicalTrials.gov/show/NCT02035787 Recruiting UNC Lineberger Comprehensive Cancer Center 2022-12-31
NCT01806350 Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors https://ClinicalTrials.gov/show/NCT01806350 Completed New Mexico Cancer Care Alliance 2012-09-30
NCT03926936 FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study https://ClinicalTrials.gov/show/NCT03926936 Recruiting University Hospital, Gasthuisberg 2022-04-01
NCT00770185 Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer https://ClinicalTrials.gov/show/NCT00770185 Completed Canadian Cancer Trials Group 2012-03-19
NCT00756847 Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors https://ClinicalTrials.gov/show/NCT00756847 Completed Sanofi 2012-05-31
NCT00739830 Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6) https://ClinicalTrials.gov/show/NCT00739830 Completed Merck Sharp & Dohme Corp. 2011-02-28
NCT00732173 Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer https://ClinicalTrials.gov/show/NCT00732173 Completed Case Comprehensive Cancer Center 2010-03-31
NCT00729586 Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00729586 Completed National Cancer Institute (NCI) 2017-02-28
NCT00723255 Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00723255 Completed National Cancer Institute (NCI) 2011-07-15
NCT00703807 Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers https://ClinicalTrials.gov/show/NCT00703807 Completed Yale University 2010-05-31
NCT00659568 Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma https://ClinicalTrials.gov/show/NCT00659568 Completed National Cancer Institute (NCI) 2010-02-28
NCT00612495 Endometrial Cancer - LOHP Alone and With 5FU https://ClinicalTrials.gov/show/NCT00612495 Completed Sanofi NA
NCT00610740 CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer https://ClinicalTrials.gov/show/NCT00610740 Completed Masonic Cancer Center, University of Minnesota 2008-04-30
NCT00607607 A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer https://ClinicalTrials.gov/show/NCT00607607 Completed CASI Pharmaceuticals, Inc. 2011-06-30
NCT00595725 Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT00595725 Completed Memorial Sloan Kettering Cancer Center 2011-09-30
NCT00575952 Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer https://ClinicalTrials.gov/show/NCT00575952 Completed Gynecologic Oncology Group 2016-07-16
NCT00569257 Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors https://ClinicalTrials.gov/show/NCT00569257 Completed AEterna Zentaris 2011-07-31
NCT00545792 Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers https://ClinicalTrials.gov/show/NCT00545792 Completed Dana-Farber Cancer Institute 2010-11-30
NCT00542490 Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer https://ClinicalTrials.gov/show/NCT00542490 Completed University of Oklahoma 2016-02-29
NCT00526149 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT00526149 Completed European Organisation for Research and Treatment of Cancer - EORTC 2008-09-30
NCT00515073 Papillary Serous Carcinoma of the Endometrium https://ClinicalTrials.gov/show/NCT00515073 Completed M.D. Anderson Cancer Center 2013-05-31
NCT00513786 Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT00513786 Completed Ohio State University Comprehensive Cancer Center 2017-01-03
NCT00507741 Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) https://ClinicalTrials.gov/show/NCT00507741 Completed Endocyte 2009-04-30
NCT00505739 Mifepristone for Patients With Endometrial Cancer and LGESS https://ClinicalTrials.gov/show/NCT00505739 Completed M.D. Anderson Cancer Center 2007-10-31
NCT00483327 Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate https://ClinicalTrials.gov/show/NCT00483327 Completed NYU Langone Health 2013-10-31
NCT00482300 Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer https://ClinicalTrials.gov/show/NCT00482300 Completed University of Roma La Sapienza NA
NCT00474994 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas https://ClinicalTrials.gov/show/NCT00474994 Completed Memorial Sloan Kettering Cancer Center 2010-11-30
NCT00462969 Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer https://ClinicalTrials.gov/show/NCT00462969 Completed University of Wisconsin, Madison 2010-09-30
NCT00462826 VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00462826 Completed National Cancer Institute (NCI) 2013-01-31
NCT00448643 Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery https://ClinicalTrials.gov/show/NCT00448643 Completed University of Miami 2011-03-31
NCT00423254 Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. https://ClinicalTrials.gov/show/NCT00423254 Completed Mannkind Corporation 2009-09-30
NCT00416455 Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT00416455 Completed National Cancer Institute (NCI) 2014-09-30
NCT00411138 Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer https://ClinicalTrials.gov/show/NCT00411138 Active, not recruiting Leiden University Medical Center 2018-11-29
NCT00408655 Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00408655 Completed National Cancer Institute (NCI) 2012-01-31
NCT00401635 END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin https://ClinicalTrials.gov/show/NCT00401635 Completed National Cancer Institute, Naples NA
NCT00392769 Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00392769 Completed M.D. Anderson Cancer Center 2010-12-31
NCT00388154 Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00388154 Completed M.D. Anderson Cancer Center 2013-11-30
NCT00381888 Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer https://ClinicalTrials.gov/show/NCT00381888 Completed Masonic Cancer Center, University of Minnesota 2009-01-31
NCT00377520 A Trial for Patients With Advanced/Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00377520 Completed Eli Lilly and Company 2007-10-31
NCT00376844 External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer https://ClinicalTrials.gov/show/NCT00376844 Completed Leiden University Medical Center 2009-05-31
NCT00334321 Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT00334321 Completed Washington University School of Medicine 2011-04-30
NCT00334295 Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma. https://ClinicalTrials.gov/show/NCT00334295 Completed AstraZeneca 2011-01-31
NCT00333086 A Study of Letrozole in the Treatment of Endometrial Cancer https://ClinicalTrials.gov/show/NCT00333086 Completed Novartis 2006-06-30
NCT00331760 Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery https://ClinicalTrials.gov/show/NCT00331760 Completed Radiation Therapy Oncology Group 2009-02-28
NCT00319748 Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers https://ClinicalTrials.gov/show/NCT00319748 Completed Masonic Cancer Center, University of Minnesota 2007-12-31
NCT00315861 Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies https://ClinicalTrials.gov/show/NCT00315861 Completed SCRI Development Innovations, LLC 2008-05-31
NCT00301964 Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00301964 Completed National Cancer Institute (NCI) 2011-07-31
NCT00287885 Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer https://ClinicalTrials.gov/show/NCT00287885 Completed Masonic Cancer Center, University of Minnesota 2008-12-31
NCT00268918 Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients https://ClinicalTrials.gov/show/NCT00268918 Completed Dana-Farber Cancer Institute 2007-01-31
NCT00267488 Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00267488 Completed GlaxoSmithKline 2007-12-31
NCT00262938 Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission https://ClinicalTrials.gov/show/NCT00262938 Completed Case Comprehensive Cancer Center 2006-01-31
NCT00258362 Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00258362 Completed Masonic Cancer Center, University of Minnesota 2009-12-31
NCT00249990 Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) https://ClinicalTrials.gov/show/NCT00249990 Completed University of New Mexico 2006-07-31
NCT00247923 Endometrial Polyps: Pathophysiology and Clinical Consequences https://ClinicalTrials.gov/show/NCT00247923 Completed Oslo University Hospital NA
NCT00245050 Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer https://ClinicalTrials.gov/show/NCT00245050 Completed Case Comprehensive Cancer Center 2008-04-30
NCT00205023 Disseminated Endometrial Cancer Cells During Sonohysterography https://ClinicalTrials.gov/show/NCT00205023 Completed University of Wisconsin, Madison 2006-02-28
NCT00190697 A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment https://ClinicalTrials.gov/show/NCT00190697 Completed Eli Lilly and Company NA
NCT00171808 Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer https://ClinicalTrials.gov/show/NCT00171808 Completed Novartis 2010-05-31
NCT00134316 Cervical or Endometrial Cancer and Sexual Health Study https://ClinicalTrials.gov/show/NCT00134316 Completed University of British Columbia 2009-11-30
NCT00122343 AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) https://ClinicalTrials.gov/show/NCT00122343 Completed Merck Sharp & Dohme Corp. 2008-01-31
NCT00107445 EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer https://ClinicalTrials.gov/show/NCT00107445 Completed National Cancer Institute (NCI) 2005-09-30
NCT00099008 Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women https://ClinicalTrials.gov/show/NCT00099008 Completed UNC Lineberger Comprehensive Cancer Center 2005-07-31
NCT00096447 Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00096447 Completed National Cancer Institute (NCI) 2011-03-31
NCT00096408 Laparoscopic Approach to Cancer of the Endometrium https://ClinicalTrials.gov/show/NCT00096408 Completed Queensland Centre for Gynaecological Cancer 2016-04-30
NCT00095979 Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00095979 Completed National Cancer Institute (NCI) 2009-07-31
NCT00004915 Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00004915 Completed Northwestern University 2000-02-29
NCT00002493 Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer https://ClinicalTrials.gov/show/NCT00002493 Completed Gynecologic Oncology Group 2001-04-30
NCT00003267 Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer https://ClinicalTrials.gov/show/NCT00003267 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-07-31
NCT00087685 RAD001 in Recurrent Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT00087685 Completed M.D. Anderson Cancer Center 2015-01-31
NCT00087100 Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00087100 Completed Gynecologic Oncology Group 2007-08-31
NCT00003946 Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00003946 Completed Gynecologic Oncology Group 2003-06-30
NCT00003691 Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00003691 Completed Gynecologic Oncology Group 2004-06-30
NCT00003127 S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer https://ClinicalTrials.gov/show/NCT00003127 Completed Southwest Oncology Group 2003-04-30
NCT00004251 Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT00004251 Completed Canadian Cancer Trials Group 2002-09-13
NCT00002949 Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis https://ClinicalTrials.gov/show/NCT00002949 Completed University of Chicago 2000-11-30
NCT00085332 Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) https://ClinicalTrials.gov/show/NCT00085332 Completed Gynecologic Oncology Group 2005-12-31
NCT00003939 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00003939 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-11-30
NCT00003669 Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT00003669 Completed Eli Lilly and Company NA
NCT00006357 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00006357 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-04-30
NCT00002764 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00002764 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-11-30
NCT00005643 Chemotherapy in Treating Patients With Sarcoma of the Uterus https://ClinicalTrials.gov/show/NCT00005643 Completed Gynecologic Oncology Group 2005-03-31
NCT00004082 Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors https://ClinicalTrials.gov/show/NCT00004082 Completed National Cancer Institute (NCI) 2003-09-30
NCT00005031 Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer https://ClinicalTrials.gov/show/NCT00005031 Completed Gynecologic Oncology Group 2004-10-31
NCT00002459 Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus https://ClinicalTrials.gov/show/NCT00002459 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-08-31
NCT00003334 Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract https://ClinicalTrials.gov/show/NCT00003334 Completed NYU Langone Health 2001-12-31
NCT00072176 Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00072176 Completed National Cancer Institute (NCI) 2009-05-31
NCT00071929 Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00071929 Completed National Cancer Institute (NCI) NA
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00025467 Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00025467 Completed National Cancer Institute (NCI) 2007-07-31
NCT00063999 Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00063999 Active, not recruiting Gynecologic Oncology Group 2013-06-29
NCT00006377 Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00006377 Completed Memorial Sloan Kettering Cancer Center 2003-01-31
NCT00005861 Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00005861 Completed Gynecologic Oncology Group 2005-08-31
NCT00053794 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00053794 Completed Canadian Cancer Trials Group 2004-09-18
NCT00052312 Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer https://ClinicalTrials.gov/show/NCT00052312 Completed European Organisation for Research and Treatment of Cancer - EORTC 2006-09-30
NCT00033605 Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis https://ClinicalTrials.gov/show/NCT00033605 Completed Alliance for Clinical Trials in Oncology 2006-07-31
NCT00033358 Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer https://ClinicalTrials.gov/show/NCT00033358 Completed National Cancer Institute (NCI) 2007-10-31
NCT00032162 Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer https://ClinicalTrials.gov/show/NCT00032162 Completed AGO Study Group 2005-05-31
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00030485 Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer https://ClinicalTrials.gov/show/NCT00030485 Completed National Cancer Institute (NCI) 2007-04-30
NCT00028535 Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT00028535 Completed National Cancer Institute (NCI) 2009-02-28
NCT00023894 Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00023894 Completed National Cancer Institute (NCI) NA
NCT00022620 Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer https://ClinicalTrials.gov/show/NCT00022620 Completed European Organisation for Research and Treatment of Cancer - EORTC 2002-10-31
NCT00019331 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT00019331 Completed National Cancer Institute (NCI) NA
NCT00006027 Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer https://ClinicalTrials.gov/show/NCT00006027 Completed Radiation Therapy Oncology Group 2004-06-30
NCT00006005 Thalidomide in Treating Patients With Gynecologic Sarcomas https://ClinicalTrials.gov/show/NCT00006005 Completed National Cancer Institute (NCI) NA
NCT00005840 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer https://ClinicalTrials.gov/show/NCT00005840 Completed Gynecologic Oncology Group 2009-07-31
NCT00005583 Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT00005583 Completed National Cancer Institute (NCI) NA
NCT00003749 Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer https://ClinicalTrials.gov/show/NCT00003749 Completed National Cancer Institute (NCI) NA
NCT00002920 S9630, Medroxyprogesterone in Treating Women With Breast Cancer https://ClinicalTrials.gov/show/NCT00002920 Completed Southwest Oncology Group 2006-12-31
NCT00002807 Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery https://ClinicalTrials.gov/show/NCT00002807 Completed Canadian Cancer Trials Group 2007-12-31
NCT00002641 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00002641 Completed European Organisation for Research and Treatment of Cancer - EORTC 2006-02-28
NCT00050440 Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT00050440 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00010829 Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors https://ClinicalTrials.gov/show/NCT00010829 Completed National Center for Complementary and Integrative Health (NCCIH) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT00342446 A Follow-up Study of Women Evaluated and Treated for Infertility https://ClinicalTrials.gov/show/NCT00342446 Completed National Institutes of Health Clinical Center (CC) NA
NCT03824613 Urinary miRNA in Endometrial Cancer Study https://ClinicalTrials.gov/show/NCT03824613 Recruiting Royal Cornwall Hospitals Trust 2021-02-01
NCT03330015 Patient’s Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding https://ClinicalTrials.gov/show/NCT03330015 Completed Chinese University of Hong Kong 2017-06-26
NCT03322176 Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing https://ClinicalTrials.gov/show/NCT03322176 Enrolling by invitation Data Collection Analysis Business Management 2020-10-17
NCT03298100 Risk Scoring Model for Endometrial Cancer https://ClinicalTrials.gov/show/NCT03298100 Active, not recruiting Ain Shams University 2019-02-28
NCT03291275 Survival Outcomes of Uterine Malignancies in Chinese Population https://ClinicalTrials.gov/show/NCT03291275 Recruiting Peking Union Medical College Hospital 2022-09-01
NCT03291106 Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer https://ClinicalTrials.gov/show/NCT03291106 Recruiting Peking Union Medical College Hospital 2019-10-01
NCT03000192 HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life https://ClinicalTrials.gov/show/NCT03000192 Active, not recruiting University Hospital Southampton NHS Foundation Trust 2020-12-31
NCT02987777 Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer https://ClinicalTrials.gov/show/NCT02987777 Completed Institut de Cancérologie de Lorraine 2016-08-31
NCT02943811 Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer https://ClinicalTrials.gov/show/NCT02943811 Completed Università degli Studi dell’Insubria 2016-10-31
NCT02912767 Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer https://ClinicalTrials.gov/show/NCT02912767 Completed Memorial Sloan Kettering Cancer Center 2020-06-01
NCT02865889 Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications https://ClinicalTrials.gov/show/NCT02865889 Completed Institut Paoli-Calmettes 2013-03-31
NCT02852954 Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells. https://ClinicalTrials.gov/show/NCT02852954 Completed Kayseri Education and Research Hospital 2016-12-31
NCT02834988 Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer https://ClinicalTrials.gov/show/NCT02834988 Completed University of Miami 2020-01-14
NCT02826291 SLNM in Endometrial Cancer Combined With OSNA https://ClinicalTrials.gov/show/NCT02826291 Completed Charles University, Czech Republic 2018-01-31
NCT02824328 A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers https://ClinicalTrials.gov/show/NCT02824328 Active, not recruiting Duke University 2020-12-31
NCT02774395 Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine https://ClinicalTrials.gov/show/NCT02774395 Completed Centre Hospitalier Universitaire de Nice 2018-05-31
NCT02724501 Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer https://ClinicalTrials.gov/show/NCT02724501 Completed University Health Network, Toronto 2011-10-31
NCT02667431 Cancer of the Uterus and Treatment of Stress Urinary Incontinence https://ClinicalTrials.gov/show/NCT02667431 Active, not recruiting Women and Infants Hospital of Rhode Island 2019-04-30
NCT00339651 Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer https://ClinicalTrials.gov/show/NCT00339651 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT02545348 Use of the Sentinel Node Biopsy for Early Endometrial Cancer. https://ClinicalTrials.gov/show/NCT02545348 Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2020-08-31
NCT02506816 Preoperative Olaparib Endometrial Carcinoma Study (POLEN) https://ClinicalTrials.gov/show/NCT02506816 Completed MedSIR 2018-07-31
NCT02335775 Lymph Node Counts in Endometrial Cancer Staging https://ClinicalTrials.gov/show/NCT02335775 Completed Duke University 2015-03-31
NCT02296307 DOvEE - Diagnosing Ovarian & Endometrial Cancer Early https://ClinicalTrials.gov/show/NCT02296307 Recruiting McGill University 2020-09-30
NCT02288676 DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics https://ClinicalTrials.gov/show/NCT02288676 Recruiting McGill University 2020-10-31
NCT02226302 Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer https://ClinicalTrials.gov/show/NCT02226302 Active, not recruiting Queensland Centre for Gynaecological Cancer 2018-05-31
NCT02093546 Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290 https://ClinicalTrials.gov/show/NCT02093546 Completed M.D. Anderson Cancer Center 2020-01-15
NCT01961102 OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer https://ClinicalTrials.gov/show/NCT01961102 Completed Krankenhaus Barmherzige Schwestern Linz 2015-09-30
NCT01914276 Lymphedema in Endometrial Cancer https://ClinicalTrials.gov/show/NCT01914276 Completed Duke University 2017-06-30
NCT01886040 Factors Affecting the Prognosis of Patients With Endometrial Cancer https://ClinicalTrials.gov/show/NCT01886040 Completed Far Eastern Memorial Hospital 2016-05-31
NCT01851928 Validation of a Nutrition Screening Tool https://ClinicalTrials.gov/show/NCT01851928 Completed Royal Marsden NHS Foundation Trust 2012-09-30
NCT01836484 Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma https://ClinicalTrials.gov/show/NCT01836484 Completed Barts & The London NHS Trust 2018-12-31
NCT01691144 Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project https://ClinicalTrials.gov/show/NCT01691144 Completed University of Oslo 2015-12-31
NCT01582906 A Survivorship Care Plan for Gynaecological Cancer Patients https://ClinicalTrials.gov/show/NCT01582906 Completed Royal Marsden NHS Foundation Trust 2014-03-31
NCT01527396 Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer https://ClinicalTrials.gov/show/NCT01527396 Completed National Cancer Center, Korea 2014-12-31
NCT01480999 Comparing Robotics and Laparoscopy With Laparotomy/Open Surgery for Endometrial Cancer https://ClinicalTrials.gov/show/NCT01480999 Active, not recruiting University Health Network, Toronto 2015-07-31
NCT01447199 The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) https://ClinicalTrials.gov/show/NCT01447199 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia https://ClinicalTrials.gov/show/NCT01444456 Completed Amgen 2013-08-31
NCT04403867 The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. https://ClinicalTrials.gov/show/NCT04403867 Recruiting Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2022-01-31
NCT04291612 Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease https://ClinicalTrials.gov/show/NCT04291612 Recruiting Memorial Sloan Kettering Cancer Center 2024-02-26
NCT04281043 Quality of Life After Robotic Surgery for Endometrial Cancer https://ClinicalTrials.gov/show/NCT04281043 Recruiting Sahlgrenska University Hospital, Sweden 2020-06-15
NCT04257045 Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives https://ClinicalTrials.gov/show/NCT04257045 Recruiting M.D. Anderson Cancer Center 2022-12-31
NCT04251676 Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis https://ClinicalTrials.gov/show/NCT04251676 Active, not recruiting National Taiwan University Hospital 2019-09-30
NCT04240730 Transvaginal Natural Orifice Endoscopic Surgery for Extremely Obese Patients With Early-stage Endometrial Cancer https://ClinicalTrials.gov/show/NCT04240730 Completed Dr. Lutfi Kirdar Kartal Training and Research Hospital 2019-06-30
NCT04212910 Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model https://ClinicalTrials.gov/show/NCT04212910 Recruiting IRCCS San Raffaele 2021-09-23
NCT04175067 Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer https://ClinicalTrials.gov/show/NCT04175067 Completed Muğla Sıtkı Koçman University 2019-10-31
NCT04010487 Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis https://ClinicalTrials.gov/show/NCT04010487 Recruiting Peking Union Medical College Hospital 2021-08-01
NCT03962140 CT Assessment of BMI in Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT03962140 Recruiting Royal Cornwall Hospitals Trust 2021-03-01
NCT03945786 Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03945786 Enrolling by invitation Xuanwu Hospital, Beijing 2020-12-31
NCT03917147 Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination https://ClinicalTrials.gov/show/NCT03917147 Completed University of Campania “Luigi Vanvitelli” 2018-10-18
NCT03898947 Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies https://ClinicalTrials.gov/show/NCT03898947 Completed Università degli Studi dell’Insubria 2016-12-31
NCT03766672 Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique https://ClinicalTrials.gov/show/NCT03766672 Recruiting University Hospital Center of Martinique 2021-01-07
NCT03744962 MSI in Circulatory DNA of Endometrial Cancer https://ClinicalTrials.gov/show/NCT03744962 Recruiting Peking Union Medical College Hospital 2020-12-23
NCT03716414 Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03716414 Completed Fudan University 2020-02-16
NCT03553589 Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03553589 Recruiting Academisch Ziekenhuis Maastricht 2021-06-01
NCT03543215 Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? https://ClinicalTrials.gov/show/NCT03543215 Recruiting Imperial College London 2020-12-10
NCT03498924 Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue https://ClinicalTrials.gov/show/NCT03498924 Completed Fundación Investigación Sanitaria en León 2018-08-01
NCT03456791 Human Epididymis Protein 4 in Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03456791 Completed Ain Shams University 2018-06-01
NCT01267851 Clinical Database and Biobank of Patients With Gynecologic Neoplasms https://ClinicalTrials.gov/show/NCT01267851 Recruiting Huazhong University of Science and Technology 2019-12-30
NCT01267357 P16 Staining as Prognostic Biomarker in Serous Papillary Endometrial Cancer https://ClinicalTrials.gov/show/NCT01267357 Completed Rambam Health Care Campus 2010-11-30
NCT01216813 Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer https://ClinicalTrials.gov/show/NCT01216813 Completed National Cancer Institute (NCI) 2010-10-31
NCT01208467 Prognostic Biomarkers in Patients With Endometrial Cancer https://ClinicalTrials.gov/show/NCT01208467 Completed Gynecologic Oncology Group 2014-05-31
NCT01075386 The Effects of the Endocrine System on Endometrial Cancer https://ClinicalTrials.gov/show/NCT01075386 Completed Queensland Centre for Gynaecological Cancer 2011-08-31
NCT01049126 Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT01049126 Completed Precision Therapeutics 2009-10-31
NCT00909896 Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy https://ClinicalTrials.gov/show/NCT00909896 Completed Ohio State University Comprehensive Cancer Center 2013-01-29
NCT00879840 Assessment of Screening Modalities for Gynecologic Cancers https://ClinicalTrials.gov/show/NCT00879840 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT03813719 Anxiety and Distress Levels in Women With Suspected Endometrial Cancer https://ClinicalTrials.gov/show/NCT03813719 Completed Imperial College London 2019-07-01
NCT03538665 The DETECT Study: Discovery and Evaluation of Testing for Endometrial Cancer in Tampons https://ClinicalTrials.gov/show/NCT03538665 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT02833896 Endometrial Cancer and Array CGH https://ClinicalTrials.gov/show/NCT02833896 Completed CHU de Reims 2016-03-31
NCT04214964 Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study https://ClinicalTrials.gov/show/NCT04214964 Recruiting Tongji Hospital 2020-10-31
NCT00340808 Molecular Staging of Endometrial Cancer https://ClinicalTrials.gov/show/NCT00340808 Completed National Institutes of Health Clinical Center (CC) NA
NCT04412902 Predictors of Recurrence for High Risk Endometrial Cancer Patients https://ClinicalTrials.gov/show/NCT04412902 Recruiting Far Eastern Memorial Hospital 2020-12-31
NCT03285230 The French E3N Prospective Cohort Study https://ClinicalTrials.gov/show/NCT03285230 Active, not recruiting Institut National de la Santé Et de la Recherche Médicale, France 1991-11-15
NCT01793545 Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples https://ClinicalTrials.gov/show/NCT01793545 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-01
NCT04334239 Effectiveness of Care in Certified Cancer Centres in Germany https://ClinicalTrials.gov/show/NCT04334239 Enrolling by invitation Technische Universität Dresden 2020-06-30
NCT00791635 Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy https://ClinicalTrials.gov/show/NCT00791635 Recruiting M.D. Anderson Cancer Center 2025-09-30
NCT00789893 Study of Vaginal Dilator Use After Pelvic Radiotherapy https://ClinicalTrials.gov/show/NCT00789893 Completed Memorial Sloan Kettering Cancer Center 2015-06-30
NCT00750672 Follow-up Care After Treatment for Endometrial Cancer https://ClinicalTrials.gov/show/NCT00750672 Completed Ottawa Hospital Research Institute 2009-09-30
NCT00735514 Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer https://ClinicalTrials.gov/show/NCT00735514 Completed Case Comprehensive Cancer Center 2010-04-30
NCT00800644 Pelvic Fractures and Radiation Therapy for Cervical Cancer https://ClinicalTrials.gov/show/NCT00800644 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT00604994 Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer https://ClinicalTrials.gov/show/NCT00604994 Completed Queensland Centre for Gynaecological Cancer 2013-01-31
NCT00587886 Estrogen, Diet, Genetics and Endometrial Cancer https://ClinicalTrials.gov/show/NCT00587886 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-12-31
NCT00581646 Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance https://ClinicalTrials.gov/show/NCT00581646 Completed Memorial Sloan Kettering Cancer Center 2015-06-30
NCT00543192 Sexual Functioning in Endometrial Cancer https://ClinicalTrials.gov/show/NCT00543192 Completed University of Wisconsin, Madison 2009-06-30
NCT00514254 Risk Factors for Endometrial Cancer in Black Women https://ClinicalTrials.gov/show/NCT00514254 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-07-31
NCT00510796 Combined Colon and Endometrial Cancer Screening in Women With HNPCC https://ClinicalTrials.gov/show/NCT00510796 Completed M.D. Anderson Cancer Center 2015-12-31
NCT00508703 Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy https://ClinicalTrials.gov/show/NCT00508703 Completed M.D. Anderson Cancer Center 2017-09-08
NCT00501761 Physical Activity After Endometrial Cancer https://ClinicalTrials.gov/show/NCT00501761 Active, not recruiting M.D. Anderson Cancer Center 2024-05-31
NCT00495235 Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas https://ClinicalTrials.gov/show/NCT00495235 Completed M.D. Anderson Cancer Center 2014-05-31
NCT00340600 Continuation of Follow-up of DES-Exposed Cohorts https://ClinicalTrials.gov/show/NCT00340600 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT00341458 Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics https://ClinicalTrials.gov/show/NCT00341458 Completed National Institutes of Health Clinical Center (CC) 2020-04-16
NCT00340262 Bone Mineral Density and Subsequent Cancer Risk https://ClinicalTrials.gov/show/NCT00340262 Completed National Institutes of Health Clinical Center (CC) 2004-12-31
NCT00340210 Extended Follow-up of Columbia, MO Serum Bank Participants https://ClinicalTrials.gov/show/NCT00340210 Completed National Institutes of Health Clinical Center (CC) NA
NCT00295945 Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer https://ClinicalTrials.gov/show/NCT00295945 Completed University of California, San Francisco 2008-04-30
NCT00288821 Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology https://ClinicalTrials.gov/show/NCT00288821 Completed UMC Utrecht 2009-03-31
NCT00277082 Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung https://ClinicalTrials.gov/show/NCT00277082 Completed University of New Mexico NA
NCT00250783 Pre-Clinical Models in Gynecological Tumors A Tissue Repository https://ClinicalTrials.gov/show/NCT00250783 Completed University of New Mexico NA
NCT00250770 Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis https://ClinicalTrials.gov/show/NCT00250770 Recruiting University of New Mexico 2022-01-31
NCT00250016 Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC) https://ClinicalTrials.gov/show/NCT00250016 Completed University of New Mexico 2007-04-30
NCT00165126 Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT00165126 Completed Dana-Farber Cancer Institute 2006-01-31
NCT00003795 Quality of Life in Survivors of Gynecologic Cancer https://ClinicalTrials.gov/show/NCT00003795 Completed Gynecologic Oncology Group 2002-03-31
NCT00005095 Specimen and Data Study for Ovarian Cancer Early Detection and Prevention https://ClinicalTrials.gov/show/NCT00005095 Recruiting Northwestern University 2020-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03112733 Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers https://ClinicalTrials.gov/show/NCT03112733 Active, not recruiting Istanbul University 2018-06-21
NCT02825355 Sentinel Node Mapping in Women With Cervical and Endometrial Cancer https://ClinicalTrials.gov/show/NCT02825355 Recruiting University of Southern Denmark 2022-10-31
NCT02012699 Integrated Cancer Repository for Cancer Research https://ClinicalTrials.gov/show/NCT02012699 Recruiting University of Nebraska 2099-12-31
NCT01761721 Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics https://ClinicalTrials.gov/show/NCT01761721 Completed Copenhagen University Hospital at Herlev 2016-02-29
NCT04290299 Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive https://ClinicalTrials.gov/show/NCT04290299 Recruiting National Cancer Institute, Naples 2025-02-01
NCT04096872 Clinical Application of Laparo-endoscopic Single-site Surgery and Natural Orifice Transluminal Endoscopic in Gynecology https://ClinicalTrials.gov/show/NCT04096872 Recruiting Peking Union Medical College Hospital 2022-10-31
NCT03931265 Ketohexokinase Isoforms in Endometrial Cancer. https://ClinicalTrials.gov/show/NCT03931265 Recruiting Far Eastern Memorial Hospital 2024-12-31
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://ClinicalTrials.gov/show/NCT03452774 Recruiting Massive Bio, Inc. 2021-12-31